Benjamin Liechty

Assistant Professor of Pathology and Laboratory Medicine

Weill Cornell Medicine
Country flagUnited States
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (3)

Pituitary neuroendocrine tumors (PitNETs) are among the most common tumors encountered in neurooncology. While the majority of PitNETs demonstrate indolent behavior, a subset of tumors demonstrates aggressive behavior, including invasion into surrounding structures. As traditional imaging has limited capacity to distinguish tumor from post-operative changes, better methods of tumor delineation are needed to guide management. Somatotroph adenomas are known to express high levels of SSTR2, and SSTR2-targeting PET imaging has shown clinical utility in the management of neuroendocrine tumors and meningiomas. In this retrospective study of archival PitNETs (n = 271) and autopsy controls (AC) (n = 20), we show that although significant differences in SSTR2 immunostaining are appreciable between adenoma subtypes and ACs, high-staining cases are encountered in all subtypes. In ACs, females demonstrated significantly stronger SSTR2 staining than males. Weak age-related trends towards increasing labelling in females and decreasing labelling in males were noted but these did not reach statistical significance. Decreasing age-related trends were seen in gonadotrophs in both sexes; this was statistically significant in females. Our findings suggest that SSTR2-targeting imaging modalities may assist clinical management of a subset of PitNETs and that these results may need to be interpreted with consideration of patient age and sex.

Year:

2025

DNA methylation is an essential molecular assay for central nervous system (CNS) tumor diagnostics. While some fusions define specific brain tumors, others occur across many different diagnoses. We performed a retrospective analysis of 219 primary CNS tumors with whole genome DNA methylation and RNA next-generation sequencing. DNA methylation profiling results were compared with RNAseq detected gene fusions. We detected 105 rare fusions involving 31 driver genes, including 23 fusions previously not implicated in brain tumors. In addition, we identified 6 multi-fusion tumors. Rare fusions and multi-fusion events can impact the diagnostic accuracy of DNA methylation by decreasing confidence in the result, such as BRAF , RAF , or FGFR1 fusions, or result in a complete mismatch, such as NTRK, EWSR1, FGFR , and ALK fusions. Implications: DNA methylation signatures need to be interpreted in the context of pathology and discordant results warrant testing for novel and rare gene fusions.

Year:

2024

DNA methylation is an essential molecular assay for central nervous system (CNS) tumor diagnostics. While some fusions define specific brain tumors, others occur across many different diagnoses. We performed a retrospective analysis of 219 primary CNS tumors with whole genome DNA methylation and RNA next-generation sequencing. DNA methylation profiling results were compared with RNAseq detected gene fusions. We detected 105 rare fusions involving 31 driver genes, including 23 fusions previously not implicated in brain tumors. In addition, we identified 6 multi-fusion tumors. Rare fusions and multi-fusion events can impact the diagnostic accuracy of DNA methylation by decreasing confidence in the result, such as BRAF , RAF , or FGFR1 fusions, or result in a complete mismatch, such as NTRK, EWSR1, FGFR , and ALK fusions. Implications: DNA methylation signatures need to be interpreted in the context of pathology and discordant results warrant testing for novel and rare gene fusions.

Year:

2024

Collaborators (11)

David Pisapia

Assistant Professor

Weill Cornell Medicine

UNITED STATES
View details

Matija Snuderl

Assistant Professor (Clinical) of Pathology

NYU School of Medicine

UNITED STATES
View details

George Jour

Associate professor

NYU Langone Medical Center

UNITED STATES
View details

Jeffrey Wisoff

Professor of Neurosurgery and Pediatrics

NYU School of Medicine

UNITED STATES
View details

Tejus Bale

Assistant Attending L1

Memorial Sloan Kettering Cancer Center

UNITED STATES
View details

Eveline Teresa Hidalgo

NYU Langone Health

UNITED STATES
View details

Jeffrey Allen

Otto and Marguerite Manley and Making Headway Foundation Professor of Pediatric Neuro-Oncology and Professor (Clinical) of Neurology

NYU School of Medicine

UNITED STATES
View details

david harter

NYU Langone Medical Center

UNITED STATES
View details

Daniel Orringer

Associate Professor

NYU Langone Health

UNITED STATES
View details

Theodore H. Schwartz

Professor

Icahn School of Medicine at Mount Sinai

UNITED STATES
View details

Sharon L Gardner

Associate Professor (Clinical) of Pediatrics

NYU School of Medicine

UNITED STATES
View details